REIIBP is a histone methyltransferase overexpressed in T(4;14) multiple myeloma with oncogenic potential

被引：0
|
作者：
Chooi, Jing Yuan [1 ]
Bin Azaman, Muhammad Irfan [2 ]
Wu, Zhengwei [2 ]
Toh, Sabrina Hui Min [2 ]
Xie, Zhigang [2 ]
Peng, Jianhe [3 ]
Chng, Wee Joo [4 ]
机构：
[1] Natl Univ Singapore, Dept Med, Singapore, Singapore
[2] Canc Sci Inst Singapore, Singapore, Singapore
[3] ASTAR, Expt Therapeut Ctr, Singapore, Singapore
[4] Natl Univ Canc Inst Singapore, Singapore, Singapore
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
BTK; REIIBP;
D O I：
10.1016/j.clml.2019.09.029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-028
引用
收藏
页码：E20 / E20
页数：1
相关论文
共 50 条
  • [1] REIIBP is a Histone Methyltransferase Overexpressed in T(4;14) Multiple Myeloma with Oncogenic Potential
    Xie, Zhigang
    Wu, Zhengwei
    Chooi, Jing Yuan
    Bin Azaman, Muhamad Irfan
    Peng, Jianhe
    Chng, Wee Joo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E53 - E54
  • [2] Differential Chromatin Organization between t(4;14) and Non-t(4;14) Multiple Myeloma Driven By the Histone Methyltransferase NSD2
    Bjorklund, Chad C.
    Zhao, Junfei
    Jain, Gaurav
    Shtraizent, Natasha
    Ortiz, Maria
    Mukherjee, Sambuddo
    Hagner, Patrick R.
    Gandhi, Anita K.
    BLOOD, 2023, 142
  • [3] The histone methyltransferase DOT1L is a potential therapeutic target in multiple myeloma
    Ishiguro, Kazuya
    Sasaki, Hajime
    Wakasugi, Hideki
    Kitajima, Hiroshi
    Niinuma, Takeshi
    Maruyama, Reo
    Kai, Masahiro
    Ikeda, Hiroshi
    Ishida, Tadao
    Sasaki, Yasushi
    Tokino, Takashi
    Nakase, Hiroshi
    Suzuki, Hiromu
    CANCER SCIENCE, 2018, 109 : 690 - 690
  • [4] A prospective study of t(4;14)multiple myeloma
    Karlin, L.
    Ghez, D.
    Choquet, S.
    Belhadj, K.
    Macro, M.
    Bouscary, D.
    Soulier, J.
    Malphettes, M.
    Asli, B.
    Brouet, J. C.
    Fermand, J. P.
    Arnulf, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 175 - 175
  • [5] Highs and lows of t(4;14) in multiple myeloma
    Paiva, Bruno
    Calasanz, Maria-Jose
    BLOOD, 2023, 141 (13) : 1500 - 1502
  • [6] A prospective study of t(4;14) multiple myeloma
    Karlin, Lionel
    Ghez, David
    Choquet, Sylvain
    Belhadj, Karim
    Macro, Margaret
    Bouscary, Didier
    Soulier, Jean
    Porcher, Raphael
    Malphettes, Marion
    Asli, Bouchra
    Brouet, Jean-Claude
    Fermand, Jean-Paul
    Arnulf, Bertrand
    BLOOD, 2007, 110 (11) : 129A - 129A
  • [7] A molecular study of the t(4;14) in multiple myeloma
    Sibley, K
    Fenton, JAL
    Dring, AM
    Ashcroft, AJ
    Rawstron, AC
    Morgan, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (02) : 514 - 520
  • [8] The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
    Martinez-Garcia, Eva
    Popovic, Relja
    Min, Dong-Joon
    Sweet, Steve M. M.
    Thomas, Paul M.
    Zamdborg, Leonid
    Heffner, Aaron
    Will, Christine
    Lamy, Laurence
    Staudt, Louis M.
    Levens, David L.
    Kelleher, Neil L.
    Licht, Jonathan D.
    BLOOD, 2011, 117 (01) : 211 - 220
  • [9] Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
    Song, Yang
    Zhang, Hao-Jun
    Song, Xia
    Geng, Jie
    Li, Hong-Yi
    Zhang, Li-Zhong
    Yang, Bo
    Lu, Xue-Chun
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (01):
  • [10] Diagnostic evaluation of t[4;14] in multiple myeloma.
    Stewart, Keith
    Trudel, Suzanne
    Chang, Hong
    Anderson, Kenneth C.
    Richardson, Paul
    Alsina, Melissa
    Reece, Donna E.
    Greipp, Philip
    Young, Steven
    Sable-Hunt, Alicia
    Li, ZhiHua
    Keats, Jonathon
    Van Wier, Scott
    BLOOD, 2006, 108 (11) : 998A - 998A
12345